Used as a key intermediate in the synthesis of fluorinated pharmaceuticals, particularly in the development of selective kinase inhibitors and antiviral agents. Its structure supports enhanced metabolic stability and binding affinity in drug candidates. Commonly employed in medicinal chemistry for constructing fluorinated aromatic scaffolds that improve bioavailability and target specificity. Also utilized in the preparation of labeled compounds for metabolic studies due to the presence of fluorine atoms suitable for 19F NMR monitoring.